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Post-translational protein modifications (PTMs) including
small chemical groups and small proteins, belonging to
the ubiquitin family, are essential for virtually all cellular
processes. In addition to modification by a single PTM,
proteins can be modified by a combination of different
modifiers, which are able to influence each other. Be-
cause little is known about crosstalk among different
ubiquitin family members, we developed an improved
method enabling identification of co-modified proteins on
a system-wide level using mass spectrometry. We fo-
cused on the role of crosstalk between SUMO and ubiq-
uitin during proteasomal degradation. Using two comple-
mentary approaches, we identified 498 proteins to be
significantly co-modified by SUMO and ubiquitin upon
MG132 treatment. These targets included many enzy-
matic components of PTM machinery, involved in
SUMOylation and ubiquitylation, but also phosphoryla-
tion, methylation and acetylation, revealing a highly com-
plex interconnected network of crosstalk among different
PTMs. In addition, various other biological processes
were found to be significantly enriched within the group of
co-modified proteins, including transcription, DNA repair
and the cell cycle. Interestingly, the latter group mostly
consisted of proteins involved in mitosis, including a
subset of chromosome segregation regulators. We hy-
pothesize that group modification by SUMO-targeted
ubiquitin ligases regulates the stability of the identified
subset of mitotic proteins, which ensures proper chro-
mosome segregation. The mitotic regulators KIF23 and
MIS18BP1 were verified to be co-modified by SUMO and
ubiquitin on inhibition of the proteasome and subse-
quently identified as novel RNF4 targets. Both modifica-
tions on MIS18BP1 were observed to increase simulta-
neously during late mitosis, whereas the total protein
level decreased immediately afterward. These results
confirm the regulation of MIS18BP1 via SUMO-ubiquitin
crosstalk during mitosis. Combined, our work highlights
extensive crosstalk between SUMO and ubiquitin, pro-
viding a resource for further unraveling of SUMO-ubiq-
uitin crosstalk. Molecular & Cellular Proteomics 16:
10.1074/mcp.TIR117.000152, 2281–2295, 2017.
The limited capacity of our genome is compensated for by
the processes of alternative splicing and post-translational
modification (PTM)1. Especially the latter adds an essential
additional layer of complexity to our proteome, which is nec-
essary to provide the cell with sufficient functionally different
protein states that are needed for efficient regulation of cel-
lular processes and pathways. In addition, PTMs provide the
cell with a rapid response mechanism to deal with changing
intracellular or environmental conditions. Modification by a
PTM can affect the function of a protein in various ways, for
example by changing its conformation, localization, binding
partners or half-life. Proteins can be modified by chemical
groups (including phosphorylation, acetylation and methyla-
tion) or by covalent attachment of small proteins (such as
ubiquitin, small ubiquitin-like modifier (SUMO), and NEDD8)
(1, 2). Ubiquitin and ubiquitin-like proteins have similar mod-
ification cascades, consisting of family-member specific ac-
tivating E1, conjugating E2, and ligating E3 enzymes (3). In
addition, each modification can be removed by specific pro-
teases (4).
From the ‡Department of Molecular Cell Biology, Leiden University
Medical Center, 2300 RC Leiden, the Netherlands
Author’s Choice—Final version free via Creative Commons
CC-BY license.
Received September 13, 2017
Published, MCP Papers in Press, September 26, 2017, DOI
10.1074/mcp.TIR117.000152
Author contributions: S.A.G.C. and A.C.O.V. designed research;
S.A.G.C. and E.W. performed research; S.A.G.C. analyzed data;
S.A.G.C. and A.C.O.V. wrote the paper.
1 The abbreviations used are: PTM, post-translational modification;
ABC, ammonium bicarbonate; ACN, acetonitrile; CAA, chloroacet-
amide; CD, catalytic domain; DMEM, dulbecco’s modified eagle’s
medium; DMSO, dimethyl sulphoxide; DTT, dithiothreitol; FA, formic
acid; FC, fold change; FCS, fetal calf serum; GOBP, gene ontology
based biological process; HEK293T, human embryonic kidney 293
cell line; IP, immunoprecipitation; LDS, Lithium Dodecyl Sulfate;
NanoLC-MS/MS, nanoflow liquid chromatography-tandem mass
spectrometry; P/S, penicillin/streptomycin; PBS/T, PBS with 0.05%
Tween-20; PD, pulldown; PEI, polyethyleneimine; RT, room temper-
ature; SIM, SUMO interaction motif; STUbL, SUMO-targeted ubiquitin
ligase; SUMO, small ubiquitin-like modifier; TFA, trifluoroacetic acid;
U2OS, human bone osteosarcoma cell line.
Technological Innovation and Resources
Author’s Choice © 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
This paper is available on line at http://www.mcponline.org
los
Molecular & Cellular Proteomics 16.12 2281
The interesting phenomenon of crosstalk among post-
translational modifications is increasingly receiving more at-
tention (5). Various crosstalk mechanisms are known that
provide an additional layer of fine tuning protein functionality.
For example, a first modification can influence a second mod-
ification on the same target, as is the case for phosphoryla-
tion-dependent ubiquitylation (6, 7) and phosphorylation-de-
pendent SUMOylation (8). In addition, modifications can
affect the function of the PTM machinery, as exemplified by
Neddylation of Cullin components in ubiquitin E3 ligases (9)
and acetylation of the SUMO E2 UBC9 (10). Finally, proteins
can be modified by specific crosstalk machinery which rec-
ognize proteins with a specific PTM and subsequently modify
these targets with a second and different PTM, including
SUMO-targeted ubiquitin ligases (STUbLs) like RNF4 (11–16).
Studying crosstalk among different PTMs can reveal essential
information about protein function that would have been
missed by focusing on single modifications. Currently, cross-
talk between ubiquitin and ubiquitin-like PTMs is mostly stud-
ied by using targeted approaches, which for example recently
identified an important role for crosstalk between SUMO and
ubiquitin in meiotic recombination among chromosomes (17).
However, addressing arising questions about crosstalk on an
unbiased proteome-wide level is challenging, because proper
purification methods are missing due to technical challenges
and low stoichiometry of modified proteins (18).
Here, we have developed an improved strategy to purify
and identify proteins co-modified by two different small pro-
tein PTMs, SUMO, and ubiquitin. This improved method is
generic and can be applied to different combinations of these
PTMs and will thereby enable us to study the phenomenon of
crosstalk on a more comprehensive PTM-wide level.
EXPERIMENTAL PROCEDURES
Cell Culture and Treatments—U2OS and HEK293T cells were cul-
tured at 5% CO2 and 37 °C in DMEM (Thermo Fisher Scientific,
Bremen, Germany) including 10% FCS (Thermo Fisher Scientific), 100
U/ml penicillin, and 100 mg/ml streptomycin (Thermo Fisher Scien-
tific). When indicated cells were selected with 2.5 M puromycin
(Calbiochem, Darmstadt, Germany) to obtain stable co-expressing
cell lines, treated with 10 M MG132 (Sigma, Saint Louis, MO) for 6 h
to inhibit the proteasome or infected with lentivirus encoding shRNAs
at an MOI of 3 to obtain protein knockdown. Cell synchronization was
achieved by incubation with 4 mM thymidine (Sigma) or 0.1 g/ml
nocodazole (Sigma) and confirmed by flow cytometry using pro-
pidium iodide (Sigma) to visualize cellular DNA content.
His10-pulldown—Purification of His10-SUMO2 conjugates was per-
formed as described before (19). In short, cell lysates were incubated
with Ni-NTA beads (Qiagen, Hilden, Germany) overnight at 4 °C,
washed and eluted for 30 min at room temperature (RT). When
indicated, eluted samples were diluted and treated with the catalytic
domain (CD) of USP2 (Boston Biochem, Cambridge, MA) and/or
SENP2 (Boston Biochem) for 3 h at RT to deconjugate ubiquitin
and/or SUMO respectively from its target proteins.
Purification of Co-modified Proteins by His10-pulldown and FLAG-
immunoprecipitation—Cells were lysed according to our His10-pull-
down protocol (19) and samples were incubated with Ni-NTA beads,
washed and eluted. Upon concentration and stepwise dilution, sam-
ples were incubated with anti-FLAG-M2 beads (Sigma). Subse-
quently, samples were washed and prepared for immunoblotting or
mass spectrometry analysis.
Electrophoresis and Immunoblotting—Proteins were separated on
Novex 4–12% Bis-Tris Plus gradient gels (Life Technologies, Carls-
bad, CA) in MOPS buffer for 45 min at 165 Volt and transferred onto
Hybond nitrocellulose membranes (GE Healthcare, Chicago, IL) in
cold transfer buffer at 25 V for 3 h. Membranes were blocked in PBS
containing 0.05% Tween-20 (Merck, Darmstadt, Germany) and 8%
milk powder, followed by incubation with primary antibodies. After
washing three times in PBS with 0.05% Tween-20 (PBS/T), the mem-
branes were incubated with secondary antibodies and washed an-
other three times in PBS/T. Pierce ECL 2 immunoblotting substrate
(Life Technologies) was used to visualize the signal on RX Medical
films (Fuji, Tokyo, Japan).
Mass Spectrometry Sample Preparation—After digestion with tryp-
sin (Promega, Madison, WI), samples were acidified by trifluoroacetic
acid (Sigma). Stage tips containing C18 (Sigma) were activated by
passing HPLC-grade methanol (Sigma), washed with 80% acetonitrile
(ACN, Sigma) in 0.1% formic acid (FA, Sigma) and equilibrated with
0.1% FA. Upon loading the samples and washing twice with 0.1% FA,
the stage tips were dried completely and eluted twice with 80% ACN.
The samples were vacuum dried using a SpeedVac RC10.10 (Jouan,
Nantes, France), redissolved in 0.1% FA and transferred to autoloader
vials before measurement by mass spectrometry.
Mass Spectrometry Experimental Design and Statistical Ration-
ale—For each experimental condition at least four biological repli-
cates were performed to allow detection of significant differences,
which were all measured in technical triplicate by nanoflow liquid
chromatography-tandem mass spectrometry (nanoLC-MS/MS).
Samples were measured on an EASY-nLC 1000 system (Proxeon,
Odense, Denmark) connected to an Orbitrap Q-Exactive (Thermo
Fisher Scientific) through a nano-electrospray ion source. Peptides
were separated in a 13 cm analytical column with an inner-diameter of
75 m, which was packed in-house with 1.8 m C18 beads (Repro-
spher, Ammerbuch-Entringen, Germany). A gradient length was used
of 60 min from 2% to 95% ACN in 0.1% FA with a flow rate of 200
nl/minute. The data-dependent acquisition mode with a top 10
method was used to operate the mass spectrometer. Full-scan MS
spectra were acquired at a target value of 3  106 with a resolution of
70,000. The higher-collisional dissociation tandem mass spectra were
recorded at a target value of 1  105 and a resolution of 17,500 with
a normalized collision energy of 25%. The maximum injection times
for MS1 and MS2 were respectively 20 ms and 100 ms. For 60 s, the
precursor ion masses of scanned ions were dynamically excluded
from MS/MS analysis. Ions with a charge of 1 or greater than 6 were
excluded from triggering MS2 events.
Subsequently, the raw data analysis was performed using Max-
Quant Software version 1.5.3.30 with its integrated search engine
Andromeda. A first search was carried out with 20 ppm for precursor
ions, followed by a main search using 4.5 ppm. To search against the
in silico digested proteome containing 92,180 entries of Homo sapi-
ens from UniProt (24 March 2016), the mass tolerance of MS/MS
spectra were set to 20 ppm. In addition, MS/MS data were searched
by Andromeda for potential common mass spectrometry contami-
nants. Trypsin/P specificity was used to perform database searches,
allowing four missed cleavages. In addition, carbamidomethylation of
cysteine residues was considered as a fixed modification, whereas
oxidation of methionines, N-terminal carbamylation and acetylation,
and diGly modification on lysines were considered as variable mod-
ifications. Match between runs was performed with a 20 min align-
ment time window and a 0.7 min match time window, while a mini-
mum peptide length of 7 was used. To consider proteins for
quantification, at least two identified peptides were required, includ-
Converging SUMO and Ubiquitin Signaling
2282 Molecular & Cellular Proteomics 16.12
ing unique and razor peptides. Proteins and peptides were identified
using a false discovery rate of 1% (20). Finally, label-free quantifica-
tion was performed using LFQ settings with fast LFQ disabled to
quantify all identified peptides (supplemental Table S1). Because
substantial differences among conditions were expected, LFQ nor-
malization by MaxQuant was skipped to prevent undesirable correc-
tion among these samples. Proteins identified by the same set of
peptides were combined to a single protein group by MaxQuant
(supplemental Table S2).
The proteins identified in each sample were further analyzed using
Perseus Software version 1.5.2.4. Samples from DMSO and MG132
treated cells were analyzed separately to prevent incorrect imputa-
tion. Both data sets were filtered for potentially improper protein
identifications by removing proteins that would fit the categories
“potential contaminant,” “reverse,” or “only identified by site.” Sub-
sequently, all LFQ intensities were log2 transformed and all experi-
mental replicates for each condition were assigned together in four
groups per treatment for the main analysis. Finally, all proteins were
removed that were not identified in at least four experimental repli-
cates in at least one of these four groups. For an additional tailored
analysis in the supplementary data, the experimental conditions of
both approaches were pooled together and assigned to two groups
per treatment to increase the statistical power. Proteins that were not
identified in at least eight pooled replicates of these two groups were
removed. For both analyses missing values were imputed based on
the total matrix of each data set, using normally distributed values
with a randomized 0.3 width (log2) and a 1.8 down shift (log2).
Two-sample Student T-tests were performed between the SUMO
and ubiquitin expressing cell line samples and their corresponding
U2OS control samples to obtain p values, their FDR corrected q
values and differences for each protein. Finally, four volcano plots
were created showing these p values (as -Log10(p)) on the y axis and
differences (as Log2FC (fold change)) on the x axis for the His10-
SUMO2/FLAG-ubiquitin purification under DMSO and MG132 condi-
tions, and for the His10-ubiquitin/FLAG-SUMO2 purification under
DMSO and MG132 conditions.
To identify significantly co-modified proteins, a false discovery rate
of 3% was accepted and all proteins with a q value over 0.03 were
removed. To increase the reliability of our data set, we overlaid the
co-modified proteins identified by both independent purification ap-
proaches and thereby obtained two robust lists of proteins co-mod-
ified by SUMO and ubiquitin upon DMSO or MG132 treatment. Sig-
nificance was determined similarly for the additional tailored analysis
described above. However, because samples of both approaches
were pooled, this analysis directly resulted in one list of proteins
co-modified upon DMSO treatment and a second one containing
co-modified proteins upon MG132 treatment. Subsequently, the pro-
teins of each list were annotated using the gene ontology annotation
of biological processes (GOBP). Enrichment of specific processes
was determined by comparison with the Human proteome obtained
from Uniprot containing 20577 proteins. Fisher exact tests were per-
formed and the enrichment of a biological process was considered to
be significant if its Benjamini-Hochberg FDR value was below 0.03.
Additionally, interactions among co-modified proteins were identified
using the STRING database version 10.0 with a medium confidence
of 0.400. Subsequently this interconnected network and the data from
Perseus were imported in Cytoscape version 3.5.0 to visualize the
interaction among proteins of specific biological processes and their
individual values as a co-modified target.
Although the samples were not specifically enriched for modified
peptides, a search was performed by MaxQuant to identify peptides
modified by a diGly motif (supplemental Table S3). Subsequently, all
peptides modified by a diGly motif that were identified equally or more
in the parental control samples, compared with the samples from cell
lines expressing both SUMO2 and ubiquitin, were considered as
ubiquitylated background binders and therefore removed from the
list. In addition, all peptides assigned to the ubiquitin precursor
UBA52 instead of to ubiquitin, or with lower quality spectra were
removed to obtain a list containing peptides modified by a diGly motif
that were specifically identified in the samples containing co-modified
proteins. For each peptide the best localization evidence spectrum
was retrieved from MaxQuant (supplemental PDF S1). Manual inspec-
tion of MS/MS spectra following the Andromeda search was per-
formed to remove potential false positive identifications.
GST-RNF4 Binding Experiment—A His10-pulldown was performed
and the samples were diluted to enable protein renaturing as de-
scribed above. Samples were incubated with control GST or recom-
binant GST-RNF4 bound Glutathione Sepharose 4 Fast Flow beads
(GE Healthcare) for 2 h at 4 °C while moving. Unbound samples
were taken, followed by washing four times with wash buffer con-
taining 50 mM Tris (pH 7.5), 150 mM NaCl, 1% Triton X-100 and
protease inhibitors without EDTA. Samples were eluted for 30 min
at 1200 rpm in wash buffer supplemented with 20 mM glutathione
(Sigma).
RESULTS
Improved Strategy Enables Purification of Co-modified Pro-
teins—We have developed an improved method that enables
enrichment of proteins simultaneously modified by two differ-
ent small protein PTMs. Many technical challenges, especially
for ubiquitin and ubiquitin-like PTMs, prevented system-wide
approaches to uncover novel crosstalk on a comprehensive
and proteome-wide level. Our improved method makes use of
two consecutive purifications, namely enrichment for a spe-
cific His10-tagged protein modifier followed by immunopre-
cipitation (IP) of a different FLAG-tagged protein modifier. As
an example, Fig. 1A shows the experimental workflow of this
method applied on a sample obtained from cells expressing
His10-SUMO2 and FLAG-ubiquitin. By expressing a differen-
tially tagged version of both protein modifiers of interest at
close to endogenous levels, subsequent purifications enabled
enrichment of co-modified proteins. In our approach we fo-
cused on co-modification of target proteins by two key PTMs,
namely ubiquitin and SUMO. However, this method could be
used to study crosstalk among many different ubiquitin-like
PTMs by simply changing the expressed modifiers.
First, two novel cell lines were created to enable two com-
plementary experimental approaches which would increase
the reliability of our data. For the first approach, U2OS cells
stably expressing His10-SUMO2 (19) were infected with len-
tivirus encoding a FLAG-ubiquitin construct. Upon selection
with puromycin, a stable cell line was created, expressing
both His10-tagged SUMO2 and FLAG-tagged ubiquitin (Fig.
1B). For the complementary approach, an additional cell line
was made which expressed both His10-tagged ubiquitin and
FLAG-tagged SUMO2. To obtain this cell line, U2OS cells
stably expressing FLAG-SUMO2 (21) were infected with len-
tivirus encoding a His10-ubiquitin construct and selected with
puromycin (Fig. 1C). Upon co-purification, the second purifi-
cation step would enrich co-modified proteins from the pool
of SUMOylated target proteins (Approach 1) or from the pool
Converging SUMO and Ubiquitin Signaling
Molecular & Cellular Proteomics 16.12 2283
of ubiquitylated target proteins (Approach 2). The overlap
between both approaches would be considered as highly
reliable co-modified target proteins.
Majority of Co-modified Proteins are Directly Modified by
SUMO and Ubiquitin—Because our improved method would


























































































































































































FIG. 1. Improved strategy to purify co-modified target proteins and validation of new cell lines. A, Cartoon depicting the improved
strategy to purify proteins simultaneously modified by two different ubiquitin family members, using His10-tagged SUMO2 and FLAG-tagged
ubiquitin as an example. Cell lines expressing His10-SUMO2 and FLAG-ubiquitin are lysed in a denaturing buffer to inactivate proteases and
disrupt noncovalent interactions. Upon His10-pulldown, the His10-SUMO2 and the target proteins covalently attached to this PTM are purified.
Samples are concentrated and free His10-SUMO2 is removed, followed by a FLAG-IP to enrich for proteins simultaneously modified by SUMO2
and ubiquitin. Co-modified proteins were also purified from cells expressing His10-ubiquitin and FLAG-SUMO2, according to a similar strategy. B,
Parental U2OS cells and U2OS cells expressing His10-SUMO2 and FLAG-ubiquitin were lysed and expression levels were analyzed by immuno-
blotting using antibodies against polyHistidine, SUMO2/3, FLAG and ubiquitin. C. Parental U2OS cells and U2OS cells expressing His10-ubiquitin
and FLAG-SUMO2 were lysed and analyzed by immunoblotting using antibodies against polyHistidine, ubiquitin, FLAG and SUMO2/3.
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well as proteins modified by chains consisting of both SUMO
and ubiquitin, an experiment was performed to determine the
fraction of proteins modified by such potential mixed chains.
A His10-pulldown was performed from cells expressing His10-
SUMO2 and the sample was treated with the catalytic domain
(CD) of SENP2 and/or USP2. If both PTMs would be cova-
lently attached directly and independently to their target pro-
teins, the SENP2CD treatment should not affect the ubiquitin
signal and the USP2CD treatment should not affect the
SUMO2/3 signal (supplemental Fig. S1A top). However, if
these target proteins would be modified by any form of mixed
SUMO-ubiquitin chains, these treatments should co-de-
crease the SUMO2/3 and/or the ubiquitin signal (supplemen-
tal Fig. S1A bottom). Immunoblot analysis showed no de-
crease in the SUMO2/3 signal on USP2CD treatment and no
decrease in the ubiquitin signal on SENP2CD treatment, re-
vealing limited purification of target proteins modified by
mixed SUMO-ubiquitin and/or mixed ubiquitin-SUMO chains
(supplemental Fig. S1B). Similar results were obtained from
cells treated with MG132, indicating that the role for mixed
chains of SUMO and ubiquitin is also limited upon inhibition of
the proteasome (supplemental Fig. S1C).
Identification of Proteins Co-modified by SUMO and Ubiq-
uitin—As shortly mentioned above, two complementary ex-
periments were performed to identify co-modified proteins
(Fig. 2 top). For the first approach, we used parental U2OS
cells as a negative control and U2OS cells that expressed
His10-SUMO2 and FLAG-ubiquitin. The second approach
made use of parental U2OS cells and U2OS cells expressing
His10-ubiquitin and FLAG-SUMO2. Because several targeted
approaches studying co-modification of single proteins indi-
cated a potential important role for crosstalk between SUMO
and ubiquitin in regulating the half-life of proteins by affecting
their degradation by the proteasome, we decided to purify
co-modified proteins from cells treated with either DMSO as a
control or MG132 to inhibit the proteasome. This resulted in
four experimental conditions per approach. Upon His10-pull-
down, SUMOylated targets were purified from the samples in
the first approach, followed by enrichment of proteins co-
modified by both SUMO2 and ubiquitin. Upon His10-pulldown
from the samples of the second approach, ubiquitylated tar-
gets were purified, followed by enrichment of co-modified
proteins.
In addition to analysis by mass spectrometry, a fraction of
each sample was saved for analysis by immunoblotting to
control for purification efficiencies. Equal amounts of starting
material were loaded for the samples taken after the first
purification (PD) and for the samples taken after double puri-
fications (PDIP). Immunoblot analysis using an antibody
against polyHistidine revealed a decrease in SUMOylated tar-
get proteins upon the second purification of the first ex-
perimental approach, indicating that only a fraction of the
SUMOylated proteins is simultaneously ubiquitylated (supple-
mental Fig. S2A). Analysis of the same samples using an
antibody against FLAG revealed limited loss of co-modified
targets present among the SUMOylated proteins during the
second purification step (supplemental Fig. S2B). To assess
whether proteins did not crash during dilution and renatur-
ation, equal amounts of starting material were loaded for
samples taken after the first purification (PD), of the potential
pellet after dilution (pellet) and after both purifications
(PDIP). Immunoblot analysis using an antibody against
polyHistidine revealed that most SUMOylated proteins were
soluble upon starting the second purification (supplemental
Fig. S2C). Immunoblot analysis of samples from the second
experimental approach indicated that only a limited fraction
of the ubiquitylated proteins is also SUMOylated (supple-
mental Fig. S2D), revealed an equally high efficiency of
the second purification step (supplemental Fig. S2E) and
proper renaturation (supplemental Fig. S2F).
Samples for mass spectrometry were prepared as de-
scribed in the experimental procedures section and analyzed
using MaxQuant and Perseus Software. In total 2061 proteins
were identified among all samples and loaded in Perseus for
further analysis. The first selection criterion eliminated any
proteins that were not identified in four replicates of at least
one of four experimental conditions per treatment, resulting in
a decrease to 282 proteins for the DMSO conditions and 1079
proteins for the MG132 conditions. On these lists, four two-
sample Student t-tests with a Benjamini Hochberg correction
were performed between each exogenous SUMO and ubiq-
uitin expressing cell line and their corresponding U2OS con-
trol to obtain p values, their FDR corrected q values and
differences for each protein. Identified proteins were consid-
ered co-modified if their q value was below 0.03. Four indi-
vidual lists of proteins were created containing targets co-
modified by SUMO and ubiquitin upon purification from
His10-SUMO2 and FLAG-ubiquitin or His10-ubiquitin and
FLAG-SUMO2 expressing cell lines both treated with DMSO
or MG132. Volcano plots showing p values (as -Log10(p)) on
the y axis and differences (as Log2FC (fold change)) on the x
axis confirmed high efficiency of both purifications, because
both SUMO2 and ubiquitin were found among the top hits in
each of these four lists (Fig. 2 bottom). The 14 “downregu-
lated” hits among the targets enriched from His10-ubiquitin
and FLAG-SUMO2 expressing cells treated with DMSO are
likely to represent background binders, which are more often
identified in the empty control samples compared with the
less empty positive samples. Both sets of co-modified pro-
teins for each treatment were purified in a complementary
order, because the co-modified proteins were enriched from
either the purified SUMOylated or ubiquitylated pool of pro-
teins. Therefore, the overlap between both lists provided us
with two lists of most highly reliable co-modified target pro-
teins, which identified 9 co-modified proteins under control
conditions and 498 proteins modified by SUMO and ubiquitin
upon proteasomal inhibition (supplemental Table S4).
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Additionally, a tailored analysis was performed by pooling
both approaches before checking for significantly co-modi-
fied targets and thereby strengthening the statistical power,
which revealed 34 co-modified targets under control condi-
tions and identified 699 proteins to be modified by SUMO and
ubiquitin after proteasomal inhibition (supplemental Fig. S3A
and supplemental Table S5). Gene ontology analysis of both
lists showed significant enrichment for various biological
processes (supplemental Table S6). Interestingly, eight pro-
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FIG. 2. Schematic overview showing experimental set-up and data analysis. Two independent approaches were used to identify target
proteins co-modified by SUMO and ubiquitin upon DMSO or MG132 treatment. For the first approach, parental U2OS cells and U2OS cells
expressing His10-SUMO2 and FLAG-ubiquitin were treated with DMSO or MG132 to inhibit the proteasome. Upon performing our improved
co-purification strategy, the SUMOylated target proteins were purified first, followed by the enrichment of co-modified proteins by SUMO and
ubiquitin. For the complementary second approach, parental U2OS cells and U2OS cells expressing His10-ubiquitin and FLAG-SUMO2 were
treated with DMSO or MG132. During the co-purification strategy, the ubiquitylated target proteins were purified first, followed by the
enrichment of co-modified proteins by SUMO and ubiquitin. Volcano plots for each condition show the p value (as -Log10(p)) and difference
(as Log2FC (fold change)) for each identified protein, of which the colored targets above the dashed line were significantly enriched with a
q value below 0.03. By focusing on the overlap between both approaches, two lists of target proteins were generated consisting of 9
co-modified proteins under control conditions and 498 co-modified proteins upon inhibition of the proteasome.
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co-modified targets under control conditions and not upon
inhibition of proteasomal degradation, indicating a potential
role for crosstalk between SUMO and ubiquitin in regulation of
DNA modification under control conditions (supplemental Fig.
S3B/S3C).
Many Enzymes Involved in the Process of Modification Itself
Are Co-modified, Indicating Extensive Crosstalk—Interest-
ingly, within the 498 proteins found by our main and more
stringent analysis to be co-modified by SUMO and ubiquitin
upon inhibition of the proteasome, many enzymes were iden-
tified that are known to be involved in the process of post-
translational modification itself. Gene ontology analysis re-
vealed a significant enrichment of proteins involved in the
general process of protein modification, but also the more
specific processes of protein SUMOylation and protein ubiq-
uitylation (Fig. 3A and supplemental Table S6). Analyzing
these data in more detail, we identified exactly which proteins
involved in (de)SUMOylation and (de)ubiquitylation were co-
modified upon inhibition of the proteasome (Fig. 3B/3C and
supplemental Table S7). Although the modifications on these
PTM machinery components should be studied in more detail,
it could be the result of auto-modification and have limited
effect on the function of these proteins. However, to our
surprise, we did not only identify co-modification by SUMO
and ubiquitin on SUMOylation and ubiquitylation machinery,
but also on many enzymes involved in other PTMs. Among the
targets identified to be SUMOylated and ubiquitylated upon
MG132 treatment, a significant enrichment was observed for
proteins involved in the biological process of protein phos-
phorylation (Fig. 3D). Additionally, proteins involved in modi-
fication by other PTMs, such as acetylation and methylation,





























































































































































Average log2FC -ln(multiplied q values)
7.5
17.5
FIG. 3. Detailed analysis of the co-modified targets reveals extensive potential crosstalk among PTMs. A, Significantly enriched
co-modified targets upon inhibition of the proteasome were annotated and a gene ontology enrichment analysis was performed. For various
biological processes involved in protein modification, their Benjamini Hochberg corrected p value (as -Log10(FDR)) and enrichment factor are
shown. The dashed line indicates the significance cutoff at an FDR of 0.03. B, Co-modified proteins annotated among the biological processes
of protein SUMOylation or deSUMOylation were identified and their interactions based on the STRING database as shown. Larger circle size
corresponds to a lower q value and darker color indicates a higher difference. C, like B, except containing co-modified proteins annotated with
the biological processes of protein ubiquitylation or deubiquitylation. D, like B, but showing co-modified proteins annotated to the biological
processes of protein phosphorylation and dephosphorylation. E, Co-modified proteins annotated to the more general process of protein
modification that were not shown in B–D, including targets involved in protein (de)methylation (orange border) and (de)acetylation (triangles).
Larger shape size corresponds to a lower q value and darker color indicates a higher difference.
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network of crosstalk among different PTMs, which might reg-
ulate each other’s machinery and thereby highlight the com-
plexity and interconnectivity of post-translational protein
modifications.
Enrichment of Functionally Distinct Protein Groups Includ-
ing Mitotic Regulators—Although more details about cross-
talk between SUMO and ubiquitin remain to be discovered,
two human SUMO-targeted ubiquitin ligases (STUbLs) are cur-
rently known (11). RNF4 and RNF111 contain SUMO interaction
motifs (SIMs), which enable them to bind SUMOylated proteins
and subsequently covalently attach ubiquitin to these targets.
Until now only a handful of target proteins has been identified
for these STUbLs, mostly through targeted approaches. Us-
ing our improved system-wide method many more proteins
were found to be co-modified by SUMO and ubiquitin specif-
ically upon inhibition of the proteasome, which could also
include STUbL targets. This was verified by the identification
of the known RNF4 targets PML, MYC, and KDM5B (22–24)
among our 498 hits (Fig. 4A). In addition to these known
STUbL targets, many more proteins were identified whose
degradation is potentially regulated through crosstalk be-
tween SUMO and ubiquitin. To analyze these potential STUBL
targets, a gene ontology enrichment analysis was performed
(supplemental Table S6). A selection of various significantly
enriched biological processes is shown in Fig. 4B/4C. More
detailed analysis revealed which proteins involved in tran-
scription and DNA repair were identified to be SUMOylated
and ubiquitylated upon inhibition of the proteasome (Fig.
4D/4E). Interestingly, the significantly enriched group of
proteins involved in the biological process of the cell cycle
mostly consisted of proteins with important roles in mitosis
(Fig. 4F).
The striking identification of this interesting group of mitotic
regulators was also confirmed by the identification of a
significant enrichment for the more specific group of pro-
teins involved in chromosome segregation. We therefore
decided to verify the mass spectrometry data by analyzing
two newly identified proteins with important roles during
mitosis via immunoblotting. Co-modification upon inhibition
of the proteasome of both MIS18BP1 and KIF23 was con-
firmed by immunoblot analysis using both complementary
purification approaches (supplemental Fig. S4 and S5;
Fig 5).
Follow-up Reveals KIF23 and MIS18BP1 as Novel RNF4
Targets—Knockdown of the STUbL RNF4 is known to result
in chromosome segregation errors (25), indicating a regulatory
role for this STUbL during mitotic progression. However, we
are limited in our understanding of the relevant target pro-
teins. Interestingly, gene ontology analysis revealed a signifi-
cant enrichment for proteins involved in the biological process
of chromosome segregation among the targets identified in
our screen as co-modified proteins upon inhibition of the
proteasome and consequently as potential novel RNF4 tar-
gets. To test this hypothesis, U2OS cells expressing His10-
SUMO2 were infected with lentiviruses encoding three inde-
pendent shRNAs directed against RNF4. As negative
controls, both parental U2OS cells and His10-SUMO2 ex-
pressing U2OS cells were infected with a lentivirus encoding
a nontargeting control shRNA. After His10-SUMO pulldown,
immunoblot analysis showed increased SUMOylation levels
of MIS18BP1 and KIF23 upon knockdown of RNF4 and
thereby revealed both mitotic regulators as novel targets
of the STUbL RNF4 (Fig. 6A). Under control conditions,
SUMOylated MIS18BP1 and KIF23 are recognized by RNF4
and subsequently ubiquitylated, resulting in proteasomal
degradation of the co-modified protein fraction (Fig. 6B).
Upon knockdown of RNF4, the SUMOylated fraction of
MIS18BP1 and KIF23 is no longer co-modified and degraded,
resulting in a stabilization of this specific fraction.
To confirm direct regulation by RNF4, an in vitro binding
assay was performed (Fig. 6C). U2OS cell lines without and
with stable expression of His10-SUMO2 were synchronized
into mitosis by releasing them for 16 h from a thymidine block.
Input samples were taken, a His10-SUMO pulldown was per-
formed to enrich for SUMOylated proteins and samples were
diluted to allow protein renaturation. Immunoblot analysis
showed the presence of SUMOylated MIS18BP1 in the pull-
down sample from His10-SUMO2 expressing cells (Fig. 6D).
Incubation of both pulldown samples with either control or
GST-RNF4 bound beads enabled purification of RNF4 inter-
acting proteins. Although we have been unable to detect
direct binding of KIF23 to RNF4, immunoblot analysis did
reveal binding of SUMOylated MIS18BP1 to this STUbL (Fig.
6E) and thereby provided additional evidence for regulation of
SUMOylated MIS18BP1 by RNF4.
Dynamic Modification of MIS18BP1 Indicates Regulation of
Mitosis by RNF4—Because the effect of RNF4 knockdown
and binding assay was most prominent in the fraction of
SUMOylated MIS18BP1, the dynamics of the modifications
on this important regulator of chromosome segregation were
studied in more detail. U2OS cells expressing His10-SUMO2
were synchronized using two independent blocking agents
into various stages of the cell cycle. After His10-pulldown and
immunoblot analysis, SUMOylation of MIS18BP1 was ob-
served to increase during late mitosis (Fig. 7A), which is
represented by the samples released 16 h or 2 to 4 h after
respectively thymidine or nocodazole block (supplemental
Fig. S6A). Upon analysis of samples obtained similarly from
cells expressing His10-ubiquitin, also the ubiquitylation of
MIS18BP1 was shown to be increased in samples enriched
for cells in late mitosis (Fig. 7B and supplemental Fig. S6B).
Interestingly, the total protein level of MIS18BP1 was ob-
served to decrease in the input samples directly following the
time points showing increased modification levels, namely at
20 h and 8 h after release from respectively thymidine and
nocodazole.
The observed decrease in protein stability just after modi-
fication by SUMO and ubiquitin indicated that RNF4 regulates
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FIG. 4. Enriched protein groups within co-modified targets upon proteasome inhibition. A, Volcano plot showing a group of known
STUbL targets in red identified among the significantly co-modified proteins upon MG132 treatment, which are highlighted in blue. B, Gene
ontology analysis revealed significant enrichment for various biological processes among the identified co-modified targets upon MG132
treatment. For a selection of these processes the FDR value of their enrichment is shown as a -Log10(FDR). C, like B, but showing the
enrichment factor for each of the selected biological processes. D, Co-modified proteins annotated among the biological process of
transcription were identified and their interactions based on the STRING database as shown. Larger circle size corresponds to a lower q value
and darker color indicates a higher difference. E, like D, but showing co-modified proteins annotated to the biological process of DNA repair.
F, Co-modified proteins annotated to the biological process of the cell cycle, including targets involved in the more specific process of mitotic
cell cycle (orange outline). Larger shape size corresponds to a lower q value and darker color indicates a higher difference.
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MIS18BP1 protein half-life by crosstalk between SUMO and
ubiquitin during mitosis. In addition, we hypothesize that
many of the other mitotic regulators identified to be co-
modified by SUMO and ubiquitin, including KIF23, are reg-
ulated by RNF4 during mitosis in a similar fashion (Fig. 7C).
Finally, group modification by RNF4 of these important mi-
totic regulators might be essential for proper chromosome
segregation (Fig. 7D). In the absence of RNF4, crosstalk
between SUMO and ubiquitin is blocked, resulting in a
stabilization of the SUMOylated form of the identified group
of mitotic proteins and subsequently chromosome segrega-
tion errors. Thereby, this project did not only discover the
extent and complexity of crosstalk among different PTMs, it
also revealed a large network of mitotic proteins modified by
SUMO and ubiquitin to regulate error-free chromosome
segregation.
DISCUSSION
Improved Methodology Enables Identification of Co-modi-
fied Proteins by SUMO and Ubiquitin—Crosstalk among
different ubiquitin-like modifiers was previously investigated
using single target protein approaches, uncovering PML (12),
PML-RAR (13), MDC1 (26–29), HIF2 (30), Tax (31), XPC
(32), PARP1 (33), CENPI (34), KDM5B (23, 24), c-Myc (22, 35),
and TRIM28 (36) as target proteins. Here, we report on a
system-wide proteomic analysis of crosstalk between SUMO
and ubiquitin. In this project, we have overcome technical
challenges by designing an improved and efficient method to
sequentially purify proteins modified simultaneously by two
different PTMs. Because this improved strategy can be ap-
plied to different combinations of various ubiquitin-like mod-
ifiers, it will enable to enhance our knowledge about crosstalk
on a PTM-wide level.
For the current project, we focused on the identification of
crosstalk between SUMO and ubiquitin involved in protea-
somal degradation. Switching the tags on each modifier and
thereby performing two independent approaches enabled
stringent filtering and more reliable identification of co-modi-
fied proteins by mass spectrometry. An interesting significant
enrichment for biological processes involved in DNA modifi-
cation was observed specifically among the co-modified pro-
teins identified upon DMSO treatment, indicating the exis-
tence of crosstalk under control conditions and thereby re-
vealing a novel area of potential research. However, the extent
of co-modified proteins greatly increased upon inhibition of
the proteasome, indicating a prominent role for crosstalk be-
tween SUMO and ubiquitin in protein degradation. A set of
498 targets was found to be co-modified upon MG132 treat-
ment, including protein groups involved in transcription, DNA
repair and the cell cycle. We identified most targets that are
known to be co-modified by SUMO and ubiquitin, including
PML, KDM5B, c-Myc and TRIM28, which confirms the reli-
ability of our method. Other known targets, such as PML-
RAR and Tax, are not expressed in U2OS cells and could











































































FIG. 5. Verification of MIS18BP1 and KIF23 as co-modified targets upon inhibition of the proteasome. Parental U2OS cells, U2OS cells
expressing His10-ubiquitin and U2OS cells expressing His10-ubiquitin and FLAG-SUMO2 were treated with DMSO or MG132 to inhibit the
proteasome. Samples were taken before the His10-pulldown (input), after the His10-pulldown (PD) and after the FLAG-IP (PDIP), and analyzed
by immunoblotting with antibodies against MIS18BP1, KIF23, polyHistidine and FLAG. An equal percentage of the sample was loaded for the
PD and PDIP samples to enable comparison. The asterisk represents an a-specific band.
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targets could be only co-modified on specific stimuli of the
cell such as DNA damage, hypoxia or enrichment for a spe-
cific cell cycle phase.
Co-modification of the identified targets can be the result of
various mechanisms, which could subsequently result in dif-
ferent effects on protein function. Our improved method will
purify proteins directly modified by both SUMO and ubiquitin
as well as proteins modified by a chain consisting of both
SUMO and ubiquitin (12). Because the role of these potential
mixed chains is mostly unknown, it would be interesting to
study their possible involvement in protein signaling. How-
ever, our experimental results showed that the abundance of
these chains is limited, indicating that most of the identified
proteins are actually directly and independently modified by
SUMO and ubiquitin via different acceptor lysines in these
target proteins.
We decided to focus our search for co-modified targets at














































































































































































FIG. 6. Identification of MIS18BP1 and KIF23 as novel RNF4 targets. A, U2OS cells expressing His10-SUMO2 were infected with lentivirus
encoding control shRNAs or three independent shRNAs against RNF4. Input and PD samples were analyzed by immunoblotting using
antibodies against RNF4, MIS18BP1, KIF23, and SUMO2/3. B, Cartoon depicting the role of RNF4 in the regulation of MIS18BP1 and KIF23.
Both important mitotic regulators are SUMOylated and thereby recognized by RNF4, which subsequently ubiquitylates these proteins and
targets them for degradation by the proteasome. Upon knockdown of endogenous RNF4, the SUMOylated fraction of MIS18BP1 and KIF23
can no longer be ubiquitylated, which results in stabilization of their SUMOylated fraction. C, Cartoon showing the experimental set-up used
to study binding of MIS18BP1 to RNF4. After enrichment for SUMOylated proteins by His10-pulldown, the samples were incubated with GST
or GST-RNF4 bound to beads to purify RNF4 binders. D, U2OS cells without or with stable expression of His10-SUMO2 were synchronized
into mitosis and lysed for pulldown. Input and His10-SUMO2 pulldown samples were analyzed by immunoblotting with an antibody against
MIS18BP1. E, After incubation of the pulldown samples with GST or GST-RNF4 bound to beads, unbound samples were taken and analyzed
by immunoblotting against MIS18BP1. Upon washing, the samples were eluted and analyzed by immunoblotting with antibodies against
MIS18BP1 and RNF4.
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ally, we identified a set of ubiquitin modification sites. How-
ever, due to low stoichiometry of co-modified proteins and
especially of the specific modified peptides, it is challenging
to identify a large set of modification sites on these proteins.
Therefore, a less complete overview of the co-modified pro-
teins would probably be identified by focusing on the level of
modified peptides. Moreover, the use of wild-type SUMO2
largely precluded the identification of SUMO acceptor lysines
(37). A search for diGly motifs by MaxQuant identified 28
peptides modified by ubiquitin that were specifically enriched
in the samples containing co-modified proteins (supplemental
Table S8). Interestingly, the recent rise in identification of
ubiquitylation as well as SUMOylation sites has provided us
with a great resource of known modified amino acids in many
proteins. By searching both the PhosphoSitePlus database
(38) and a recent review which compared all studies identify-
ing SUMOylation sites (37), we found that one or more
SUMOylation or ubiquitylation sites were already identified for
respectively 68% or 90% of all 498 co-modified proteins
enriched upon inhibition of the proteasome (supplemental
Table S9). This analysis shows the rich amount of site infor-
mation that is already available and indicates that most of our









































































































































































































































FIG. 7. Regulation of MIS18BP1 during mitosis and the role of RNF4. A, U2OS cells expressing His10-SUMO2 were synchronized using
two independent cell cycle blocking agents and released for the indicated time periods to reach various cell cycle phases. A His10-pulldown
was performed and the samples were analyzed by immunoblotting using antibodies against MIS18BP1 and SUMO2/3. B, U2OS cells
expressing His10-ubiquitin were synchronized as described above. Input and pulldown samples were analyzed by immunoblotting with
antibodies against MIS18BP1 and ubiquitin. C, Cartoon depicting the regulation of various proteins with important roles during mitosis,
including MIS18BP1, by the SUMO-targeted ubiquitin ligase RNF4. A subset of mitotic regulators is recognized by RNF4 through its
SUMOylation and subsequently ubiquitylated and degraded by the proteasome. D. Cartoon showing regulation of chromosome segregation
by RNF4. Knockdown of RNF4 results in mitotic problems including chromosome segregation errors. We hypothesize that this phenotype is
caused by deregulation of a group of mitotic regulators because of the absence of RNF4.
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Interestingly, the nature of the ubiquitin-ubiquitin linkages
on the co-modified proteins is rather diverse, with virtually all
internal ubiquitin lysines involved in chain formation (supple-
mental Table S8). Surprisingly, we did not detect the lysine 48
ubiquitin linkage, despite being a hallmark for targeting pro-
teins to the proteasome for degradation. However, other ubiq-
uitin-ubiquitin linkages are also involved in targeting proteins
to the proteasome (39). Of note, the employed N-terminal
tagging of ubiquitin and SUMO does preclude the formation
of linear chains.
While our manuscript was in preparation, an alternative
approach was published to identify proteins co-modified by
SUMO and ubiquitin (40). Thibault and co-workers employed
a His6-SUMO3 purification and a sequential ubiquitin remnant
immunoaffinity purification from lysates of HEK293 cells
treated with the proteasome inhibitor MG132. The flow-
through of the ubiquitin remnant immunoaffinity purification
was subjected to SUMO remnant immunoaffinity purification.
They found a total of 194 proteins containing ubiquitylation
sites in their pool of His6-SUMO-enriched proteins. However,
for 113 of these proteins no SUMOylation sites were identi-
fied. The authors hypothesize that these 113 proteins could
represent proteins modified by SUMO on their conjugated
ubiquitin chains. Our experiments revealed that although
mixed SUMO-ubiquitin chains are formed, most of co-modi-
fied proteins contain SUMO and ubiquitin on separate lysine
residues of the target proteins in U2OS cells. Whether the
limited role of mixed SUMO-ubiquitin chains also holds
true for other cell types, including HEK293 cells, remains to be
addressed. Additionally, the identification of ubiquitylated
proteins without SUMOylation sites could represent back-
ground binders due to the limited stringency of the His6-
approach. The identification of ubiquitylation and SUMOyla-
tion sites on 81 targets is an impressive step forward into the
technically challenging direction of studying crosstalk on a
site-specific level. By focusing on the protein level and em-
ploying a His10-approach, we have identified a substantial
larger pool of 498 co-modified proteins by SUMO and ubiq-
uitin upon inhibition of the proteasome. Therefore, we believe
that both approaches complement each other and provide us
with state-of-the-art knowledge on crosstalk between SUMO
and ubiquitin on the sites as well as protein level.
Identification of Functionally Distinct Protein Groups Among
the Co-modified Targets—Interestingly, we identified an en-
richment for proteins involved in the biological process of
protein modification itself among the targets co-modified by
SUMO and ubiquitin, showing the great extent of intercon-
nectivity among different modifications. We were expecting to
identify various SUMO E3 ligases to be co-modified on pro-
teasomal inhibition, due to their auto-SUMOylation and the
role of ubiquitylation in their degradation. However, the great
extent of identified PTM machinery, not only involved in the
process of SUMOylation but also in many other modifications
including ubiquitylation, phosphorylation, methylation and
acetylation, let us to believe that we have revealed a complex
network that is regulated by PTM crosstalk. Future studies will
have to unravel this extra layer of crosstalk and will potentially
identify additional layers by other PTM combinations, reveal-
ing the interesting phenomenon of modified modifiers.
In addition to regulating PTM machinery, our results show
that crosstalk can regulate many other proteins involved in a
wide variety of gene ontology annotated biological processes.
These target proteins can be co-modified by various crosstalk
mechanisms. The best studied mechanism of crosstalk be-
tween SUMO and ubiquitin is modification by SUMO-targeted
ubiquitin ligases. Two STUbL enzymes are currently known in
humans, namely RNF4 and RNF111, which can recognize
SUMOylated target proteins and subsequently ubiquitylate
them. Upon inhibition of the proteasome, these co-modified
proteins are not able to be degraded and could therefore be
identified by mass spectrometry upon enrichment using our
improved strategy. Because this is currently the main mech-
anism of crosstalk between SUMO and ubiquitin involved in
proteasomal degradation, we are expecting a large fraction of
our identified proteins to be STUbL targets. Interestingly, not
all proteins identified to be co-modified upon inhibition of the
proteasome have to be targets of RNF4 or RNF111. Given the
wealth of ubiquitin E3 ligases, additional STUbLs might be
identified.
Regulation of Mitotic Proteins Via RNF4 During Cell Cycle
Progression—Various functionally different protein groups
were found among the co-modified targets, including many
mitotic regulators. Interestingly, gene ontology analysis re-
vealed significant enrichment of proteins involved in the spe-
cific process of chromosome segregation. Because knock-
down of RNF4 is known to result in chromosome segregation
errors (25), we were wondering whether this co-modified
group could be novel targets of the STUbL and thereby ex-
plain the observed phenotype. The co-modification of two
mitotic regulators was verified and both KIF23 and MIS18BP1
were indeed identified as novel RNF4 targets. In addition, the
modification dynamics of MIS18BP1 showed an increase dur-
ing late mitosis, with equal timing for its SUMOylated as well
as its ubiquitylated fraction. These results indicate that
MIS18BP1 is regulated by crosstalk between SUMO and
ubiquitin via RNF4 during mitosis, which results in its degra-
dation by the proteasome. The latter hypothesis was con-
firmed by the observation that total MIS18BP1 protein levels
were decreased in the first time-points after the increase in
modifications was observed. These results suggest that
SUMOylated MIS18BP1 is recognized by RNF4, which re-
sults in its ubiquitylation and subsequent degradation dur-
ing mitosis.
Given the important role of RNF4 in chromosome segrega-
tion, this STUbL could coregulate a group of targets relevant
for this process. By regulating the half-life of this set of pro-
teins, RNF4 uses its group modification ability and thereby
has become an essential player in chromosome segregation.
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Upon knockdown of RNF4, these proteins are not degraded
at the right time during mitosis, resulting in their stabilization
and consequently, chromosome segregation errors. Interest-
ingly, similar problems during chromosome segregation
were observed upon knockdown of the SUMO E3 ligase
PIAS4 (41), indicating a potential collaboration between
PIAS4 and RNF4 during the process of chromosome seg-
regation. According to our hypothesis, knockdown of PIAS4
would prevent SUMOylation of the identified protein group
and thereby inhibit their recognition by RNF4, which would
prevent their degradation and therefore result in a similar
phenotype as was observed for the knockdown of RNF4
itself. This hypothesis needs to be verified, which could lead
to more detailed knowledge about this crosstalk between
SUMO and ubiquitin and its role in mitotic regulation.
Concluding Remarks—We have developed improved meth-
odology that will help to increase our knowledge about cross-
talk among various PTMs. By applying this improved meth-
odology, proteins co-modified by SUMO and ubiquitin upon
inhibition of the proteasome were identified in a system-wide
manner. Interestingly, this revealed the co-modification of
important mitotic regulators, including a subset involved in
chromosome segregation. Subsequently, MIS18BP1 was
identified as a novel RNF4 target, which regulates its stability
during mitosis. We hypothesize that RNF4 is a key mitotic
regulator for the identified group of proteins, including
MIS18BP1, thereby timing their destabilization during chro-
mosome segregation. Finally, the application of this improved
method has revealed the extent of interconnectivity among
different PTMs and will help to increase our knowledge and
discover more details about crosstalk among protein modifi-
cations in the future.
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